Virbac (Australia) Pty Limited v Dermcare-Vet Pty Ltd

In the Federal Court of Australia, Virbac (Australia) Pty Limited (Virbac) brought proceedings against Dermcare-Vet Pty Ltd (Dermcare-Vet) concerning alleged breaches of contract and misleading or deceptive conduct. The dispute centred on the supply of veterinary pharmaceutical products, specifically Virbac's "Canine Spectra" range of vaccines. Virbac alleged that Dermcare-Vet had failed to meet minimum purchase obligations under a distribution agreement and had engaged in conduct likely to mislead consumers regarding the origin and nature of certain veterinary products.

The primary legal issues before the Court were whether Dermcare-Vet had breached the distribution agreement by failing to achieve the stipulated minimum purchase quantities for Virbac's products, and whether Dermcare-Vet's conduct in marketing and selling certain veterinary products constituted misleading or deceptive conduct in contravention of the *Trade Practices Act 1974* (Cth) (now the *Competition and Consumer Act 2010* (Cth)). The Court was required to interpret the terms of the distribution agreement and assess the impact of Dermcare-Vet's marketing practices on consumers.

Justice Forno found that Dermcare-Vet had indeed breached the distribution agreement by failing to meet the minimum purchase obligations. In relation to the misleading or deceptive conduct claim, the Court determined that Dermcare-Vet's representations regarding the veterinary products were likely to mislead consumers as to the source and nature of those products, thereby contravening the relevant provisions of the *Trade Practices Act 1974*. The Court applied principles of contract interpretation to ascertain the parties' obligations under the agreement and principles of consumer protection law to assess the conduct in question.

The Court ordered that Dermcare-Vet pay damages to Virbac for the breach of contract and also granted injunctive relief to prevent further misleading or deceptive conduct.